
- Head and Neck Cancers (Issue 4)
- Volume 3
- Issue 4
Ilaria Muller on a Possible Common Antigen Between Thyroid and Breast Cancers
Muller says if this common antigen does exist, an immune therapy could hypothetically be developed to combat it and essentially combat both breast and thyroid cancer.
Ilaria Muller, PhD student, Cardiff University, on a possible common antigen between thyroid cancer and breast cancer. Muller says if this common antigen does exist, an immune therapy could hypothetically be developed to combat it and essentially combat both breast and thyroid cancer.
Muller sadds that in most forms of thyroid cancer, the thyroid can be removed and replacement treatments for its function can be taken. Muller and colleagues at Cardiff Univeristy are currently investigating the topic of thyroid autoimmunity as a biomarker of outcome in women with breast cancer by way of a large-scale study using data from the Taxotere As Adjuvant Chemotherapy (Tact) Trial (Cruk01/001).
Articles in this issue
about 10 years ago
Immunotherapies Gaining Traction in Head and Neck Cancersabout 10 years ago
Dr. Sylvia Asa on Treating Different Types of Thyroid Cancerabout 10 years ago
Link Drawn Between Oral HPV and Risk of Head and Neck Cancersabout 10 years ago
Dr. Ramona Dadu on Immunotherapies and Their Role in Thyroid Cancerabout 10 years ago
Nivolumab Could Change Head and Neck Cancer Treatment Paradigmabout 10 years ago
Nivolumab Boosts OS in Phase III in SCCHN StudyRelated Content



Safety and Antitumor Activity Revealed for T-Cell Engager XmAb819 in RCC

Sarcomatoid Features May Be a Biomarker in Chromophobe RCC




























